References
- Walton B, Thorton T. Female sexual dysfunction. Curr Womens Health Rep 2003; 3: 319–326
- Sarrel P, Dobay B, Wiita B. Estrogen and estrogen–androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998; 43: 847–856
- Oettel M, Carol W, Graser T, et al. Effect of ethinyl estradiol–dienogest combination on serum androgen concentrations. Zentralbl Gynakol 1997; 119: 597–606
- Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review. Maturitas 1998; 30: 295–305
- Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191–208
- Murray W. Decreased libido in postmenopausal women. Nurse Pract Forum 2000; 11: 219–224
- Phillips N A. Female sexual dysfunction: evaluation and treatment. Am Fam Physician 2000; 62: 127–136, 141–2
- Bachmann G A, Leiblum S R. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004; 11: 120–130
- Murray W. Decreased libido in postmenopausal women. Nurse Pract Forum 2000; 11: 219–224
- Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy – effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993; 14: 283–293
- Dennerstein L, Burrows G D, Wood C, Hyman G. Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol 1980; 56: 316–322
- Nathorst-Boos J, Wiklund I, Mattsson L A, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993; 72: 656–660
- Teichmann A. Pharmacology of estradiol valerate/dienogest. Climacteric 2003; 6(Suppl 2)17–23
- Schneider H P. Androgens and antiandrogens. Ann N Y Acad Sci 2003; 997: 292–306
- Rymer J, Chapman M G, Fogelman I, Wilson P O. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994; 18: 127–133
- Palacios S, Menendez C, Jurado A R, Castano R, Vargas J C. Changes in sex behaviour after menopause: effects of tibolone. Maturitas 1995; 22: 155–161
- Laan E, van Lunsen R H, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001; 4: 28–41
- Egarter C, Topcuoglu A, Vogl S, Sator M. Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women. Acta Obstet Gynecol Scand 2002; 81: 649–653
- Kloosterboer H J. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001; 76: 231–238
- Doren M, Rubig A, Coelingh Bennink H J, Holzgreve W. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 2001; 75: 554–559